HBV
Clinical trials for HBV explained in plain language.
Never miss a new study
Get alerted when new HBV trials appear
Sign up with your email to follow new studies for HBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hepatitis b? early trial of Tune-401 begins
Disease control Recruiting nowThis early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral medication. The goal is to see if Tune-401 is safe and how the body processes it, not yet to cure the infection.
Matched conditions: HBV
Phase: PHASE1 • Sponsor: Tune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
One test, four diseases: could this be the end of missed diagnoses?
Diagnosis Recruiting nowThis study tests a new device called MagIA H3S that can screen for HIV, hepatitis B, hepatitis C, and syphilis using a single blood sample. Researchers will enroll about 2,950 people in Ivory Coast and Kenya to see how accurate the device is compared to standard lab tests. If it …
Matched conditions: HBV
Sponsor: MagIA Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Austrian study seeks to eliminate hepatitis by linking patients to care
Knowledge-focused Recruiting nowThis study in South-East Austria looks at past lab results to find people with hepatitis B, C, or D who may not know they have it. Researchers will invite these individuals to a clinic to discuss treatment options. The goal is to connect them to care and track how many get cured,…
Matched conditions: HBV
Sponsor: Vanessa Stadlbauer-Koellner, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks hidden risks of hepatitis b drugs in vulnerable patients
Knowledge-focused Recruiting nowThis study follows 490 adults with a past hepatitis B infection who need immune-suppressing treatments. Researchers will monitor bone, kidney, and metabolic health over 4 years to understand the long-term side effects of antiviral drugs. The goal is to create better safety guidel…
Matched conditions: HBV
Sponsor: Yaşar Bayındır, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Gut check: new study probes how hepatitis drug changes your microbiome
Knowledge-focused Recruiting nowThis study looks at how the drug bulevirtide changes gut bacteria and bile acids in people with hepatitis delta (a serious liver infection). Researchers will follow 20 patients for 48 weeks, collecting stool and blood samples to see how these changes relate to liver health. The g…
Matched conditions: HBV
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
New rapid test could transform hepatitis b and d management
Knowledge-focused Recruiting nowThis observational study aims to develop a rapid T-cell test to help manage patients with chronic hepatitis B (HBV) and hepatitis B/D (HBV/HDV) co-infection. Researchers will analyze immune responses in 300 adult patients to understand how T-cells react to the viruses. The goal i…
Matched conditions: HBV
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC